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1. Introduction
  Campylobacter jejuni (C. jejuni) is an important food-born zoonotic 
pathogen, and one of the leading causes of human food borne 
illnesses (Campylobacteriosis) worldwide[1,2]. The most important 
source of transmission of this pathogen to humans is through 
contaminated animal products, especially poultry meat as well as 
direct contact with cattle shedding C. jejuni, or handling raw or 
undercooked poultry[3,4]. Campylobacter has been reported from 
broiler flocks in various European countries at the prevalence rates 
ranging from 38.1% to 79.2%[5,6]. Antibiotics play a vital role in 
human and veterinary medicine for treatment and prevention of 
infections but are also used as growth promoters in food animals[7]. 
Their increased use has resulted in the increased incidences of 
infection with enteric bacteria with higher levels of antibiotic 
resistance[8]. Campylobacter spp. has developed resistance to many 
clinically important antimicrobials, including fluoroquinolones (FQ) 
during the recent past[9-12]. It is believed that their transmission and 
spread are not only affected by the environmental and host factors, 
but also are influenced by the relative fitness of the drug-resistant 
Objective: To determine antibiotic resistance patterns and virulence potential of Campylobacter 
jejuni (C. jejuni) isolates from clinical human diarrheal infections, cattle and healthy broilers. 
Methods: Antibiotic sensitivity patterns of C. jejuni isolates were determined by Kirby Bauer 
Disc Diffusion assay. These isolates were then subjected to virulence profiling for the detection 
of mapA (membrane-associated protein), cadF (fibronectin binding protein), wlaN (beta-1,3-
galactosyltransferase) and neuAB (sialic acid biosynthesis gene). Further C. jejuni isolates were 
grouped by random amplification of polymorphic DNA (RAPD) profiling. Results: A total of 
436 samples from poultry (n=88), cattle (n=216) and humans (n=132) from different locations 
were collected. Results revealed percentage of C. jejuni isolates were 35.2% (31/88), 25.0% 
(54/216) and 11.3% (15/132) among poultry, cattle and clinical human samples respectively. 
Antibiotic susceptibility results showed that similar resistance patterns to cephalothin was 
ie. 87.0%, 87.1% and 89%among humans, poultry and cattle respectively, followed by 
sulfamethoxazole+trimethoprim 40.0%, 38.7% and 31.0% in humans, poultry and cattle and 
Ampicillin 40%, 32% and 20% in humans, poultry and cattle respectively. Beta-lactamase 
activity was detected in 40.00% humans, 20.37% cattle and 32.25% in poultry C. jejuni isolates. 
CadF and mapA were present in all poultry, cattle and human C. jejuni isolates, wlaN was not 
detected in any isolate and neuAB was found in 9/31 (36%) poultry isolates. RAPD profiling 
results suggested high diversity of C. jejuni isolates. Conclusions: Detection of multidrug 
resistant C. jejuni strains from poultry and cattle is alarming as they can be potential hazard 
to humans. Moreover, predominant association of virulence factors, cadF and mapA (100 % 
each) in C. jejuni isolates from all sources and neuAB (36%) with poultry isolates suggest the 
potential source of transmission of diverse types of C. jejuni to humans. 
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organisms in the absence of selection pressure[13]. Campylobacter 
spp. has shown resistance to a large number of beta lactam 
antimicrobial agents. However, the behaviours of others, such as 
ampicillin and some of the expanded-spectrum cephalosporins, are 
variable and not very clearly defined[14].
  The current study gives the perspective of distribution of multiple 
antibiotic resistance, beta lactamase activity and virulence attribution 
to C. jejuni isolates from clinical human diarrheal infections, cattle 
and healthy broilers sharing the environment with the humans from 
the heavily populated city of Rawalpindi, Pakistan and its suburbs. 
Furthermore, their random amplification of polymorphic DNA 
(RAPD) profiling was carried out for determining their diversity. 
2. Materials and methods
2.1. Sampling 
  This study was carried out from December 2011 and December 
2012. The samples were collected from poultry slaughter houses 
from one of the country’s leading poultry producer city, cattle 
farms and human clinical diarrheal cases. A total of 436 samples 
collected consisting of 216 cattle faecal samples, 132 human clinical 
samples and 88 poultry samples. Samples were collected in sterile 
cotton swabs containing Carry-Blair medium and transported to 
Microbiology Laboratory of COMSATS Institute of Information 
Technology, Islamabad.
2.2. Culturing and isolation
  The samples collected were streaked onto modified Charcoal 
Cefoperazone Deoxycholate Agar (mCCDA) (Oxoid, CM0739) 
containing CCDA selective supplement (Oxoid, SR0155). Samples 
were incubated in 2.5 litres airtight jar along with Campygen sachets 
(Oxoid, CN025A) to generate microaerophilic condition at 42 曟 for 
48-72 hours. Suspected Campylobacter colonies were subcultured on 
Muller Hinton Agar (Oxoid, CM0337) with addition of 5% sheep 
blood[15].
2.3. Biochemical identification
  Positive growth of Campylobacter isolates was further subjected to 
standard biochemical tests consisting of oxidase, catalase, indoxyl 
acetate and hippurate. In the case of indoxyl-acetate test, change of 
colour from colourless to blue green indicative of the presence of 
Campylobacter spp. and in case of hippurate hydrolysis, development 
of blue/purple colour in hippurate solution indicated positive 
reaction for presence of C. jejuni with the production of hippuricase 
enzyme and clear or grey colouration indicate negative reaction for 
its presence. A positive test for both reactions was indicative of C. 
jejuni[16].
2.4. Molecular detection of C. jejuni
  Bacterial DNA was obtained by whole-cell lysate method as 
described by Singh et al. Primers used for confirmation of C. jejuni 
by PCR were MDS-16S rRNA (targeting 16S RNA gene), hipO 
(Hippurate hydrolysis gene) as described in Table 1. PCR was 
performed as previously described[17,18]. Amplified PCR products 
were analyzed on 1.5% agarose gel stained with ethedium bromide.  
2.5. Virulence typing
  C.  j e juni  i sola tes  were  screened for  the  presence of 
virulence genes (Table 1). Primers were designed against 
C. jejuni adhesin, cadF (fibronectin binding protein) (400 bp) gene, 
wlaN (putative beta-1,3-galactosyltransferase) (330 bp), neuAB 
(sialic acid biosynthesis gene) (755 bps) and mapA (membrane-
associated protein) (94 bps). 
2.6. RAPD PCR
  For RAPD analysis of C. jejuni OPA11 primer was used as 
described by Hernandez et al. Briefly, the reaction mixture was 
carried out in a total volume of 25 毺L containing 40 ng total DNA 
of each strain, 1.36 pM primer), 1.6 U Taq DNA polymerase (Super 
Taq), 1.5 毺L 500 mM MgCl2, 0.7 毺L 10 mM dNTPs in 1X PCR 
buffer (Fermentas). The PCR products were then separated by 1.5% 
agarose gel electrophoresis and visualized by ethidium bromide 
staining. Dendrogram was constructed using DendroUPGMA 
(genomes.urv.cat/UPGMA/) for RAPD PCR analysis.
2.7. Antimicrobial susceptibility profiling and beta-lactamase 
detection 
  Antibiotic susceptibility profiling was carried out using 
chloramphenicol C (30 毺g), tetracycline (TE) (30 毺g), 
streptomycin (S) (10 毺g), ciprofloxacin (CIP) (5 毺g), amoxicillin 
clavulenic (AMC) acid (30 毺g), nalidixic acid (NA) (30 毺
g), erythromycin (E) (30 毺g), gentamycin (CN) (10 毺g), 
sulphomethoxazole + trimethoprim (SXT) (25 毺g) and cephalothin 
(CEF), respectively (Oxoid, UK) as described by Gaudreau et al[19]. 
Analysis of zone diameter was done according to the CLSI (2010). 
Beta-lactamases were detected by use of Cefinase disks (BBL 
Microbiology Systems) as described by Lachance et al[20].
3. Results
3.1. PCR confirmation of Campylobacter isolates
  Biochemically verified C. jejuni strains were further subjected to 
PCR using primers against conserved 16S rRNA (amplification 
product 857 bps) and hip gene (hippurate hydrolysis gene) (344 bps). 
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3.2. C. jejuni distribution pattern among various sources
  Four hundred and thirty-six samples were analysed in this 
study. 100 out of a total of 436 samples were confirmed as
C. jejuni ie., the overall prevalence rate was 100/436 (22.93%). The 
isolation rate of C. jejuni was (n=31) 35.2%, (n=54) 25.0% and 
(n=15) 11.3% in poultry, cattle and humans, respectively. 
3.3. Antimicrobial susceptibility profile
  Antibiotic resistance profile of C. jejuni isolates from humans, cattle 
and poultry sources was determined using 10 antibiotics according 
to CLSI 2010. Comparison of antibiotic susceptibilities of C. jejuni 
isolates from different sources is shown in Table 2. Antibiotic 
susceptibility of the isolates revealed that resistance to cephalothin 
was the most common ie. 87.0%, 89.0% and 87.1%, followed by 
trimethoprim/sulfamethoxazole 40.0%, 38.7% and 31.0% and 
amoxicillin clavulenic acid 40%, 32% and 20% in human, cattle 
and poultry respectively (Figure 1). Multidrug resistance was also 
identified in strains from different sources (Table 3). Gentamicin was 
found to be the most sensitive antibiotic with resistance of 7%, 0% 
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Figure 1. Prevalence of antibiotic resistance among different C. jejuni 
isolates of poultry, human and cattle.
Table 2 
Percentages of antibiotic resistances of Campylobacter jejuni 
isolated from humans, poultry and cattle sources in Pakistan.
Antibiotics Humans Poultry Cattle
Chloramphenicol (30 毺g) 20 19.4 14
Tetracycline (30 毺g) 27 48.39   6
Streptomycin (10 毺g) 53 22.6 26
Ciprofloxacin (5 毺g) 20 3.23   9
Ampicillin (30 毺g) 40 32.26 20
Nalidixic acid (30 毺g) 13 38.7 23
Erythromycin (30 毺g) 27 80.6 29
Gentamycin (10 毺g)   7   0.0   9
Sulphomethoxazole + Trimethoprin (25 毺g) 40 38.7 31
Cephalothin  (30 毺g) 87 87.1 89
  Beta-lactamase production was detected in 27 C. jejuni strains 
including 6 human, 10 poultry and 11 cattle strains. Thus, the overall 
frequency of beta lactamase producing strains in our study was 
27/100 (27%).  
3.4. RAPD Profiling 
  Analysis of C. jejuni isolates by RAPD profiling yielded 22 different 
banding profiles. Almost all the C. jejuni isolates were well dispersed 
among all clusters (Figure 2). However, five isolates did not produce 
any recognizable RAPD banding pattern. 
3.5. Virulence typing
  Virulence typing was performed using 4 genes as targets and results 
suggested that cadF and mapA (adherence factors) were present in 
all isolates studied whereas neuAB (invasive factor) was found in 9 
(36%) poultry samples only, whereas wlaN (invasive factor) was not 
present in any of the isolates (Figure 3). 
Table 1 
Primers for identification and virulotyping of C. jejuni.
Primer F/R Sequence of primers Annealing 
temperature
Product    size         References
16Sr RNA F 5`-ATCTAATGGCTTAACCATTAAC-3`    55 曟 857 bp [17]
R 5`-GGACGGTAACTAGTTTAGTATT-3`
hipo F 5`-GACTTCGTGCAGATATGGATGCTT-3`    59  曟 344 bp [40]
R 5`-GCTATAACTATCCGAAGAAGCCATCA-3`
mapA F 5`-AAGCAATACCAGTGTCTAAAGTGC-3`    60  曟  94 bp [41]
R 5`-GGTTTTGAAGCAAAGATTAAAGG-3`
cadF F 5`-TTGAAGGTAATTTAGATATG-3`    45  曟 400 bp [42]
R 5`-CTAATACCTAAAGTTGAAAC-3`
neuAB F 5`-ATTATAGCCATTTGCTCACTTTG-3`    52  曟 755  bp [43]
R 5`-AAAGCACCCTTAGTCGTACCTG-3`
wlaN F 5’-TGCTGGGTATACAAAGGTTGTG-3’    60  曟 330  bp [44]
R1 3’-AATTTTGGATATGGGTGGGG-5’
R2 3’-TTAAGAGCAAGATATGAAGGTG-5’
OPA11 CAA TCG CCG T    36 曟 varied [38]
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Figure 3. Prevalence of virulence genes in C. jejuni isolates from poultry, 
humans and cattle.     
4. Discussion 
  The aim of this study was to assess the C. jejuni isolates obtained 
from different sources on the basis of antimicrobial resistance and 
thereafter screening them for virulence factors. The isolates were 
further characterized using RAPD analysis for possible relatedness. 
Little data is available from Pakistan to compare our data, previously 
isolation rates of C. jejuni from humans have been reported to be 
29.5%[21], 12%[22] and 18%[23] and 21.5% Campylobacter spp. 
prevalence in food commodities[4]. While to our knowledge no 
reports are available for C. jejuni prevalence in poultry and cattle 
from Pakistan. The higher prevalence rates 100/436 (22.93%) of 
C. jejuni in this study are in agreement with reports from other 
countries[24-30]. Antibiotic susceptibility profile of C. jejuni isolates 
was determined using 10 antibiotics and compared among poultry, 
cattle and humans isolates. The results of antimicrobial susceptibility 
testing in this study indicate that the isolates were in general resistant 
to the tested antibiotics at rates ranging from 7% to 87% in clinical 
cases, up to 87.1% in poultry and 6% to 89% in cattle. Higher rate of 
resistance (80.6%) to erythromycin was seen among C. jejuni isolates 
from poultry. Since the ingestion of the infected poultry meat may 
account for most of human campylobacteriosis cases, this fact 
becomes more relevant to public health  when seen in the context that 
Erythromycin is one of the commonly used drug for treatment of the 
patients. However, the frequency of resistance to ampicillin (40%), 
Tetracycline (27%) and gentamycin (7%) was comparable or lower 
than in the reports from most of the European countries[31,32]. Mostly 
tested isolates were susceptible to chloramphenicol and gentamycin. 
Among the isolates from different sources overall resistance rates 
were different. Tetracycline was listed as an alternative treatment 
for Campylobacter gastroenteritis in the past and they are widely 
used therapeutically and sub therapeutically as feed additives for 
livestock and poultry[33]. In our study, resistance to tetracycline (7%) 
was lower than previous reports[34-36]. The identification of multiple 
antibiotic resistant C. jejuni isolates from poultry, cattle and humans 
is alarming as such resistance strains may cause more prolonged or 
severe illness[37].  Further, 27 C. jejuni isolates of during the current 
study were B-lactamase producers. This is of significance as beta 
lactams are generally the first line of drugs for treating hospitalized 
cases. Campylobacter spp. are generally inherently resistant to many 
beta-lactams, however, there are variable reports of resistance to 
beta-lactams and some of the expanded spectrum cephalosporins 
but it is not clearly defined[14]. In our study 6 human diarrheal, 
10 poultry and 11 cattle isolates were positive for resistance to 
B-lactams. 
  Virulence typing suggested that all isolates possess adherence 
property owing to the presence of cadF and mapA genes, while 36% 
of only poultry C. jejuni isolates possess in addition invasive property 
attributable to the presence of neuAB implying their possibility of 
association with more severe disease.  RAPD typing[38] results have 
shown the presence of 8 distinct types of C. jejuni. Despite some 
limitations, analysis of Campylobacter spp. isolates using RAPD has 
proved to be useful for preliminary characterization of strains[39] 
and the dendrogram constructed showed genetic diversity of isolates 
Table 3
Multidrug resistant strains from different sources. 
Source Number of isolates (%) Multiple antibiotic resistance
Humans   5 (33.33%) Streptomycin (S), ampicillin (A), sulphomethoxazole + trimethoprin (SXT), cephalothin (CEF)
Poultry 20 (64.51%) Tetracycline (TE), ampicillin (A), nalidixic acid (NA), erythromycin (E), sulphomethoxazole + 
trimethoprin (SXT), cephalothin (CEF)
Cattle 28 (51.85%) Streptomycin (S), erythromycin (E), cephalothin (CEF)
Fariha Masood Siddiqui et al./Asian Pacific Journal of Tropical Medicine (2015)197-202 201
from different sources. Three main clusters were clearly defined 
ie. clusters 栺, 栻 and 栿 based on RAPD profiling. All invasive 
strains (strains positive for neuAB) were present in cluster I whereas 
all multidrug resistant and beta lactamase producing strains were 
randomly distributed in all clusters. Our study have shown that 
RAPD PCR assay can act as rapid and effective molecular tool, 
which can be used in any basic microbiology laboratory, for studying 
C. jejuni isolates from different sources and discriminating virulent 
strains.  
  This study analyses C. jejuni strains in Pakistani poultry, cattle 
and human diarrheal samples particularly with regard to their 
antibiotic resistance and virulence profiling. As compared with 
European surveillance programmes, the prevalence and antibiotic 
resistance of C. jejuni in Pakistan are not monitored and isolation 
of multiple antibiotic resistance C. jejuni from poultry and cattle 
during the current study serves as impetus for more elaborate 
studies regarding the prevalence and transmission patterns of
C. jejuni. 
Acknowledgements 
  The authors are thankful to British Council for providing funds for 
this project (Grant SP019) through their strategic partnership awards 
(INSPIRE Program).
Conflict of interest statement
  The authors declare no conflict of interest.                                            
References
[1]   Moore JE, Corcoran D, Dooley JS, Fanning S, Lucey B, Matsuda 
M, et al. Campylobacter. Vet Res 2005; 36: 351-382.
[2]   Silva J,  Leite D, Fernandes M, Mena C, Gibbs P, Teixeira P. 
Campylobacter spp. as a foodborne pathogen: A review. Front Microbiol 
2011; 2: 200.
[3]   Butzler PJ. Campylobacter, from obscurity to celebrity. Clin Microbiol 
Infect 2004; 10: 868-876.
[4]   Hussain I, Mahmood MS, Akhtar M, Khan A. Prevalence of 
Campylobacter species in meat, milk and other food commodities in 
Pakistan. Food Microbiol 2007; 24: 219-222.
[5]   Lawes J, Vidal A, Clifton-Hadley F, Sayers R, Rodgers J, Snow L, et al. 
Investigation of prevalence and risk factors for Campylobacter in broiler 
flocks at slaughter: results from a UK survey. Epidemiol Infect 2012; 
140:1725-37.
[6]   Torralbo A, Borge C, Allepuz A, García-Bocanegra I, Sheppard S, Perea 
A, et al. Prevalence and risk factors of Campylobacter infection in broiler 
flocks from southern Spain. Prevent Veter Med 2014; 114: 106-113.
[7]   Maron D, Smith T, Nachman K. Restrictions on antimicrobial use in 
food animal production: an international regulatory and economic survey. 
Globaliz Health 2013, 9:48.
[8]   Houndt T, Ochman H. Long-term shifts in patterns of antibiotic resistance 
in enteric bacteria. Appl Environ Microbiol 2011; 66: 5406-5409.
[9]   Taylor DE, Tracz DM. Mechanisms of antimicrobial resistance in 
Campylobacter. In: Ketley JM, Konkel ME (Eds.). Campylobacter: 
molecular and cellular biology. Norfolk: Horizon Bioscience. 2005, p. 
193-204.
[10] Payot S, Bolla JM, Corcoran D, Fanning S, Megraud F, Zhang 
Q. Mechanisms of fluoroquinolone and macrolide resistance in 
Campylobacter spp. Microbes Infect 2006; 8: 1967-1971.
[11] Smith J, Fratamico P. Fluoroquinolone resistance in campylobacter. J 
Food Prot 2010; 73: 1141-1152.
[12] Pollett S, Rocha C, Zerpa R, Patiño L, Valencia A, Camiña M, et al. 
Campylobacter antimicrobial resistance in Peru: a ten-year observational 
study. BMC Infect Dis 2012; 12:193.  
[13] Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, et al. Enhanced 
in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the 
absence of antibiotic selection pressure. Proc Natl Acad Sci USA 2005; 
102: 541-546.
[14] Wieczorek K, Osek J. Antimicrobial resistance mechanisms among 
Campylobacter. Biomed Res Int 2013; 340605.
[15] Aydon F, Atabay HI, Akan M. The isolation and characterization of 
Campylobacter jejuni subsp. jejuni from domestic geese. J Appl Microbiol 
2000; 90: 637-642.
[16] Chaban B, Ngeleka M, Hill JE. Detection and quantification of 14 
Campylobacter species in pet dogs reveals an increase in species richness 
in faeces of diarrheic animals. BMC Microbiol 2010; 10: 1-7.
[17] Cardarelli-Leite P, Blom K, Patton C, Nicholson MA, Steingerwalt AG, 
Hunter SB, et al. Rapid identification of Campylobacter species strains by 
Restriction Fragment Length Polymorphism analysis of a PCR-amplified 
fragment of the gene coding for 16S rRNA. J Clin Microbiol 1996; 34: 
62-67.
[18] Atanassova V, und Ring Ch, Nachweis von. Campylobacter spp. 
mittels RFLP Analyse und PCR Amplifikat Fragment fuer 16S 
rRNA. In: Deutschland S, editor. 41 Arbeitstagung der Arbeitsgruppe 
Lebensmittelhygiene der DVG, Garmisch-Partenkirchen. 2000, p. 383-388.
[19] Gaudreau C, Gilbert H. Comparison of disc diffusion and agar dilution 
methods for antibiotic susceptibility testing of Campylobacter jejuni 
subsp. jejuni and Campylobacter coli. J Antimicrob Chemother 1997; 39: 
707-712.
[20] Lachance N, Gaudreau C, Lamothe F, Turgelon F. Susceptibilities of 
beta-lactamase positive and -negative strains of Campylobacter coli to 
beta-lactam agents. Antimicrob Agents Chemother 1993; 37: 1174-1176.
[21] Kazmi RR, Hafeez A, Kazmi SU. Polymicrobial infection in 
Campylobacter jejuni enteritis in Karachi. FEMS Microb Lett 1987; 41: 
Fariha Masood Siddiqui et al./Asian Pacific Journal of Tropical Medicine (2015)197-202202
153-156.
[22] Khalil K, Lindblom GB, Mazhar K. Early child health in Lahore, 
Pakistan: VII. microbiology. Acta Paediatr 1993; 390: 87-94.  
[23] Ali AM, Qureshi AH, Rafi S, Roshan E, Khan I, Malik AM, et al. 
Frequency of Campylobacter jejuni in diarrhoea/dysentery in children in 
Rawalpindi and Islamabad. J Pak Med Assoc 2003; 53: 517-520.  
[24] Whyte P, McGill K, Cowley D, Madden RH, Moran L, Scates P, et al. 
Occurrence of Campylobacter in retail foods in Ireland. Int J Food Microb 
2004; 95: 111-118.
[25] Ghafir Y, China B, Dierick K, De Zutter L, Daube G. A seven survey of 
Campylobacter contamination in meat at different production stages in 
Belgium. Int J Food Microb 2007; 116: 111-120.
[26] Yildirim M, Istanbulluoglu E, Ayvali B. Prevalence and antibiotic 
susceptibility of thermophilic Campylobacter species in broiler chickens. 
Turk J Vet Animal Sci 2005; 29: 655-660.
[27] Taremi M, Dallal SMM, Gachkar L, Ardalan MS, Zolfagharian K, Zali, 
MR. Prevalence and antimicrobial resistance of Campylobacter isolated 
from retail raw chicken and beef meat, Tehran, Iran. Int J Food Microb 
2006; 108: 401-403.
[28] Bostan K, Aydin A, Ang MK. Prevalence and Antibiotic susceptibility 
of thermophilic Campylobacter species on beef, mutton and chicken 
carcasses in Istanbul, Turkey. Microb Drug Res 2009; 15: 143-149.
[29] Rahimi E, Ameri M, Kazemeini HR. Prevalence and antimicrobial 
resistance of Campylobacter species isolated from raw camel, beef, lamb 
and goat meat in Iran. Foodborne Path Dis 2010; 7: 443-447.
[30] Hassanain N. Antimicrobial resistant Campylobacter jejuni isolated from 
humans and animals in Egypt. Glob Veterinar 2011; 6: 195-200.
[31] Oporto B, Juste R, Hurtado A. Phenotypic and genotypic antimicrobial 
resistance profiles of Campylobacter jejuni isolated from cattle, sheep, and 
free-range poultry faeces. Int J Microbiol 2009. [Online]Available from: 
http://dx.doi.org/10.1155/2009/456573.
[32] Mattheus W, Botteldoorn N, Heylen K, Pochet B, Dierick K. Trend 
analysis of antimicrobial resistance in Campylobacter jejuni and 
Campylobacter coli isolated from belgian pork and poultry meat products 
using surveillance data of 2004-2009. Foodborn Pathog Dis 2012; 9: 465-
472.  
[33] Trieber CA, Taylor DE. Mechanisms of antibiotic resistance in 
Campylobacter. In: Campylobacter. 2nd ed. Washington: ASM Press; 
2000, p. 441-454.
[34] Albert M, Udo E, Jose B, Haridas S, Rotimi V. Tetracycline resistance is 
frequent among Campylobacter jejuni isolates from Kuwait. Microb Drug 
Resis 2009; 15: 115-120.
[35] Rohini R, Diana S, Harry H, Claude D, Cherie H, Cecelia Y, et al. 
Fluoroquinolone and metronidazole resistance of Campylobacter spp from 
broiler chickens and antimicrobial use on farms in Grenada, West Indies. 
J Anim Res 2012; 2: 219-227.  
[36] Wimalarathna H, Richardson J, Lawson A, Elson R, Meldrum R, Little 
C, et al. Widespread acquisition of antimicrobial resistance among 
Campylobacter isolates from UK retail poultry and evidence for clonal 
expansion of resistant lineages. BMC Microbiol 2013; 13: 160.
[37] Traver K, Barza M. Morbidity of infections caused by antimicrobial 
resistant bacteria. Clin Infect Dis 2002; 34: S131-S134.
[38] Hernandez J, Fayos A, Ferrus MA, Owen RJ. Random amplified 
polymorphic DNA fingerprinting of Campylobacter jejuni and 
Campylobacter coli isolated from human faeces, seawater and poultry 
products. Res Microbiol 1995; 146: 685-696.
[39] Elango A, Dhanalakshmi B, Pugazhenthi T, Jayalalitha V, Kumar C, 
Doraisamy K. RAPD-PCR characterization of Campylobacter jejuni 
isolates obtained from raw milk samples in Chennai. Egyp J Dairy Sci 
2009; 37: 175-181. 
[40] Persson S, Olsen KE. Multiplex PCR for identification of Campylobacter 
coli and Campylobacter jejuni from pure cultures and directly on stool 
samples. J Med Microbiol 2005; 54: 1043-1047.
[41] Stucki U, Frey J, Nicolet J, Burnens AP. Identification of Campylobacter 
jejuni on the basis of a species-specific gene that encodes a membrane 
protein. J Clin Microbiol 2005; 33: 855-859.
[42] Konkel ME, Gray SA, Kim BJ, Garvis SG, Yoon J. Identification of the 
enteropathogens Campylobacter jejuni and Campylobacter coli based on 
the cadF virulence gene and its product. J Clin Microbiol 1999; 37: 510-
517.
[43] Parker CT. Diversity in the lipooligosaccharide biosynthesis locus of 
Campylobacter jejuni. NCBI accession number AY434498. Produce 
Safety and Microbiology Unit, United States Department of Agriculture, 
Agriculture Research Service, Albany, Calif. 2004.
[44] Wassenaar TM, Wagenaar JA, Rigter A, Fearnley C, Newell DG, Duim 
B. Homonucleotide stretches in chromosomal DNA of Campylobacter 
jejuni display high frequency polymorphism as detected by direct PCR 
analysis. FEMS Microbiol Lett 2002; 212: 77-85.
